Potential value of pre- and post-therapy [68Ga]Ga-DOTA-TATE PET/CT in the prognosis of response to PRRT in disseminated neuroendocrine tumors

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) is one of the most effective therapeutic options for the treatment of metastatic, well-differentiated neuroendocrine tumors (NETs). It improves progressive disease-free survival and enables the control of hormone secretion in functioning tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Opalińska, Marta, Morawiec-Sławek, Karolina, Kania-Kuc, Adrian, Al Maraih, Ibraheem, Sowa-Staszczak, Anna, Hubalewska-Dydejczyk, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420847/
https://www.ncbi.nlm.nih.gov/pubmed/36046793
http://dx.doi.org/10.3389/fendo.2022.929391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420847/
https://www.ncbi.nlm.nih.gov/pubmed/36046793
http://dx.doi.org/10.3389/fendo.2022.929391

Ejemplares similares